KLA Corporation Total Cost of Revenue increased by 4.4% to $1.33B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 12.9%, from $1.18B to $1.33B. Over 4 years (FY 2021 to FY 2025), Total Cost of Revenue shows an upward trend with a 14.4% CAGR. This is a positive signal — lower values indicate better performance for this metric.
An increase relative to revenue suggests rising production costs or margin compression, while a decrease suggests improved operational efficiency.
Total cost of revenue includes the direct costs attributable to the production of goods or the delivery of services sold...
Varies by industry; for medical device manufacturers, this includes significant manufacturing and supply chain costs.
total_cost_of_revenue| Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $772.24M | $813.62M | $908.16M | $892.09M | $978.56M | $1.04B | $1.21B | $1.01B | $962.95M | $946.89M | $976.75M | $993.89M | $1.01B | $1.15B | $1.22B | $1.18B | $1.21B | $1.24B | $1.27B | $1.33B |
| QoQ Change | — | +5.4% | +11.6% | -1.8% | +9.7% | +6.4% | +16.1% | -16.8% | -4.2% | -1.7% | +3.2% | +1.8% | +1.7% | +13.5% | +6.5% | -3.7% | +2.7% | +3.0% | +2.3% | +4.4% |
| YoY Change | — | — | — | — | +26.7% | +28.0% | +33.1% | +12.7% | -1.6% | -9.1% | -19.2% | -1.1% | +4.9% | +21.2% | +25.1% | +18.3% | +19.5% | +8.3% | +4.1% | +12.9% |
| Segment | Q3 '26 |
|---|---|
| Semiconductor Process Control | $1.13B |
| Specialty Semiconductor Process | $88.51M |
| PCB And Component Inspection | $80.96M |
| Total | $1.33B |